New brain bleed treatment could reduce need for repeat surgery
NCT ID NCT07541404
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new device (NeoCast) that blocks a specific artery in the brain to treat a type of bleeding called subdural hematoma. The goal is to see if it works as well as or better than an existing treatment (Onyx) to prevent the blood from coming back or needing another surgery. About 360 adults with symptoms like headache or confusion will be enrolled.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUBDURAL HEMATOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Washington Medicine - Harborview Medical Center
Seattle, Washington, 98104, United States
-
Yale Neurosciences Institute
New Haven, Connecticut, 06519, United States